Synergizing vaccinations with therapeutics for measles eradication - Wikidata - thesis-toulmin - TriplyDB

Synergizing vaccinations with therapeutics for measles eradication

Synergizing vaccinations with therapeutics for measles eradication

http://www.wikidata.org/entity/Q27003149

about

Measles Virus Fusion Protein: Structure, Function and Inhibition Organization, Function, and Therapeutic Targeting of the Morbillivirus RNA-Dependent RNA Polymerase Complex Sequential conformational changes in the morbillivirus attachment protein initiate the membrane fusion process Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens.Population Bottlenecks and Pathogen Extinction: "Make This Everyone's Mission to Mars, Including Yours"Morbillivirus infections: an introduction.The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics.Polymerases of paramyxoviruses and pneumoviruses.Mutations in the Fusion Protein of Measles Virus That Confer Resistance to the Membrane Fusion Inhibitors Carbobenzoxy-d-Phe-l-Phe-Gly and 4-Nitro-2-Phenylacetyl Amino-Benzamide.

P2860

Q26750552-EF414104-2D2D-4C5D-AADF-8A6829CB8247 Q27468732-CBE4B001-1B0C-4AF9-8B7D-26A41C2368DC Q28547034-938D1E45-2CC2-488A-8693-DFA31CC01B66 Q35755496-E83C5773-BA48-44FB-8943-CA47C12D432F Q35914379-77080C6C-DF92-4A94-9F4E-1C8E1453A4BD Q38357057-8341C217-BC7A-4030-BB30-113C68B8E8DD Q38510112-B6E7078D-11D6-4E05-B787-C4E5FD2B3998 Q39011481-6F492B74-F930-40C9-82FB-E0F617343068 Q40042437-29C018A4-C7AC-4F51-B552-2308AD340330

P2860

Synergizing vaccinations with therapeutics for measles eradication

http://www.wikidata.org/entity/Q27003149

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Synergizing vaccinations with therapeutics for measles eradication

@ast

Synergizing vaccinations with therapeutics for measles eradication

@en

Synergizing vaccinations with therapeutics for measles eradication

@nl

type

label

Synergizing vaccinations with therapeutics for measles eradication

@ast

Synergizing vaccinations with therapeutics for measles eradication

@en

Synergizing vaccinations with therapeutics for measles eradication

@nl

prefLabel

Synergizing vaccinations with therapeutics for measles eradication

@ast

Synergizing vaccinations with therapeutics for measles eradication

@en

Synergizing vaccinations with therapeutics for measles eradication

@nl

P1433

Q27003149-57CCA847-427A-495F-9CFE-C5437A00794B

P1476

Q27003149-6CFDD977-E6B6-498C-8C96-4DBEF73B1E61

P2093

Q27003149-4CF84511-856D-4727-80AC-3B392B0FA301

Q27003149-86D85824-0B19-42D1-8085-739E0AAAEACB

P2860

Q27003149-00FF97A1-8A85-46DD-B30A-333867682332

Q27003149-023070A3-1B59-4A5E-BF93-F034083470FA

Q27003149-02F8554C-41D3-4B88-B1FA-B9412730835E

Q27003149-04DD86C5-C9D2-4631-86E9-D69A9363B087

Q27003149-057D9F3B-5039-41BC-92D7-556239F2C848

Q27003149-0980D59E-9CE2-4BFB-9C49-A5B979C5D9CB

Q27003149-0D340F53-63F7-4FA6-8163-3F1047392819

Q27003149-100B34EF-A5DC-4C0E-804C-625D39C1A396

Q27003149-12106793-84E7-440E-A1DF-DB132B2A20A6

Q27003149-13519242-A31E-4A3B-B948-5E1EE9E18BE4

P304

Q27003149-24729E6D-7C93-4620-99F3-D9DE1CE874D9

P31

Q27003149-8453AA7F-8488-41D2-A512-264159E9EC4B

P3181

Q27003149-F9D1DF79-7D26-432A-9A93-1F6CDB82A21B

P356

Q27003149-A3128292-A43A-4284-95AE-AADC51BFD28B

P407

Q27003149-D9ECF8F3-9837-4E95-899B-56C5E91ED691

P433

Q27003149-3CA31101-65A6-47E6-BEC3-150C40D96778

P478

Q27003149-2540F801-7928-40D9-B150-F15C3368C2AC

P577

Q27003149-144E74B9-1ACC-4690-A60C-920B552195CF

P698

Q27003149-BED34BBD-27D7-4DBC-91D8-78FEBF45EEFF

P921

Q27003149-7EC43015-AD07-49C0-9A4E-8FC6CD19E2F1

Q27003149-990C1F47-FADE-4E48-9FA2-05EDF159C8E2

P932

Q27003149-B1C45F61-94D9-4119-B165-C722711B066F

P3181

P356

17460441.2014.867324

P1433

Expert Opinion on Drug Discovery

P1476

Synergizing vaccinations with therapeutics for measles eradication

@en

P2093

Anthea L Hammond

http://www.w3.org/2001/XMLSchema#string

Richard K Plemper

http://www.w3.org/2001/XMLSchema#string

P2860

Antibiotics for preventing complications in children with measles

Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity

Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature.

Cell entry of enveloped viruses

Early target cells of measles virus after aerosol infection of non-human primates

Measles immune suppression: lessons from the macaque model

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Retraction of an interpretation

RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized

P304

201-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2164443

http://www.w3.org/2001/XMLSchema#string

P356

10.1517/17460441.2014.867324

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24303998

http://www.w3.org/2001/XMLSchema#string

P921

eradication of infectious diseases

P932

4050436

http://www.w3.org/2001/XMLSchema#string